This inventor holds 2 USPTO granted patents. Top assignee: Imperial Chemical Industries Limited. Active years: 1984-1993.
Company Filing History:
Years Active: 1984-1993
Title: Michael T. Cox: Innovator in Pharmaceutical Chemistry
Introduction
Michael T. Cox is a notable inventor based in Congleton, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing novel compounds that have potential therapeutic applications.
Latest Patents
Cox's latest patents include the invention of benzheterocyclyl sulphones. This invention concerns novel, pharmaceutically useful compounds that can be utilized in treating diabetic complications. The compounds are characterized by specific structural formulas, which include various substituents and linking groups. Another significant patent involves homocyclic derivatives that act as antagonists at opiate receptors, with many being selective delta-receptor antagonists. These compounds also include processes for their manufacture and pharmaceutical compositions for medical use.
Career Highlights
Michael T. Cox is associated with Imperial Chemical Industries Limited, where he has been instrumental in advancing pharmaceutical research. His work has led to the development of compounds that are not only innovative but also have the potential to improve patient outcomes in various medical conditions.
Collaborations
Cox collaborates with David R. Brittain, contributing to the advancement of their shared research interests in pharmaceutical chemistry.
Conclusion
Michael T. Cox's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His patents reflect a commitment to developing effective treatments for complex medical issues.